Caxton Corp Kala Pharmaceuticals, Inc. Transaction History

Caxton Corp

  • $23.3 Million
  • Q3 2024

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$0.61 - $1.84 $8,024 - $24,205
-13,155 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$1.16 - $2.74 $1.99 Million - $4.7 Million
-1,714,596 Reduced 99.24%
13,155 $16,000
Q3 2021

Nov 15, 2021
BUY
$2.62 - $5.43 $60,003 - $124,357
22,902 Added 1.34%
1,727,751 $4.53 Million
Q2 2021

Aug 16, 2021
BUY
$5.06 - $8.15 $1.39 Million - $2.24 Million
274,828 Added 19.22%
1,704,849 $9.04 Million
Q1 2021

May 17, 2021
BUY
$6.24 - $9.58 $1.8 Million - $2.76 Million
287,661 Added 25.18%
1,430,021 $9.64 Million
Q4 2020

Feb 16, 2021
BUY
$6.28 - $8.79 $2.33 Million - $3.26 Million
370,570 Added 48.01%
1,142,360 $7.75 Million
Q3 2020

Nov 16, 2020
BUY
$7.5 - $11.11 $1.14 Million - $1.68 Million
151,501 Added 24.42%
771,790 $5.79 Million
Q2 2020

Aug 14, 2020
SELL
$8.33 - $13.79 $10.1 Million - $16.8 Million
-1,216,024 Reduced 66.22%
620,289 $6.52 Million
Q1 2020

May 15, 2020
BUY
$3.83 - $8.79 $1.35 Million - $3.1 Million
352,970 Added 23.8%
1,836,313 $16.1 Million
Q3 2019

Nov 14, 2019
SELL
$3.57 - $6.58 $74,716 - $137,712
-20,929 Reduced 1.39%
1,483,343 $5.64 Million
Q2 2019

Aug 14, 2019
BUY
$4.93 - $8.8 $14,790 - $26,400
3,000 Added 0.2%
1,504,272 $9.6 Million
Q1 2019

May 14, 2019
BUY
$5.19 - $8.97 $745,455 - $1.29 Million
143,633 Added 10.58%
1,501,272 $12.4 Million
Q4 2018

Feb 14, 2019
BUY
$4.29 - $9.94 $5.6 Million - $13 Million
1,306,380 Added 2548.59%
1,357,639 $6.64 Million
Q3 2018

Nov 14, 2018
BUY
$9.54 - $13.87 $489,010 - $710,962
51,259 New
51,259 $506,000
Q1 2018

May 15, 2018
SELL
$12.26 - $18.98 $6.67 Million - $10.3 Million
-544,220 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$19.86 - $26.53 $10.8 Million - $14.4 Million
544,220
544,220 $12.4 Million

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Caxton Corp Portfolio

Follow Caxton Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Corp, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email